ES8502989A1 - Un metodo de preparar compuestos de diaminopirimidina - Google Patents

Un metodo de preparar compuestos de diaminopirimidina

Info

Publication number
ES8502989A1
ES8502989A1 ES525490A ES525490A ES8502989A1 ES 8502989 A1 ES8502989 A1 ES 8502989A1 ES 525490 A ES525490 A ES 525490A ES 525490 A ES525490 A ES 525490A ES 8502989 A1 ES8502989 A1 ES 8502989A1
Authority
ES
Spain
Prior art keywords
diaminopyrimidines
production
pyrimidinediamine
piperazinyl
antibacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES525490A
Other languages
English (en)
Other versions
ES525490A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of ES525490A0 publication Critical patent/ES525490A0/es
Publication of ES8502989A1 publication Critical patent/ES8502989A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

METODO DE PREPARAR COMPUESTOS DE DIAMINOPIRIMIDINA.COMPRENDE HACER REACCIONAR UN COMPUESTO DE FORMULA (II), CON UN COMPUESTO FLUORFENILICO SUSTITUIDO DE FORMULA (III) PARA OBTENER UN COMPUESTO DE DIAMINOPIRIMIDINA DE FORMULA (I) EN DONDE R1 ES H O ALCOHILO C 1 A 6; R2 Y R3 SON INDEPENDIENTEMENTE H, O METILO; R4 Y R5 SON INDEPENDIENTEMENTE H, HIDROXILO, NITRO, CIANO, ALCOHILO DE C 1 A 6, ALCOXILO DE C 1 A 6 Y OTROS. LA REACCION SE EFECTUA EN UN DISOLVENTE ORGANICO POLAR Y EN PRESENCIA DE UNA BASE.TIENE APLICACIONES FARMACEUTICAS POR POSEER PROPIEDADES ANTIBACTERIANAS Y ANTITUMORALES.
ES525490A 1982-09-09 1983-09-08 Un metodo de preparar compuestos de diaminopirimidina Expired ES8502989A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41640482A 1982-09-09 1982-09-09
US06/520,653 US4532240A (en) 1982-09-09 1983-08-09 Diaminopyrimidines

Publications (2)

Publication Number Publication Date
ES525490A0 ES525490A0 (es) 1985-02-01
ES8502989A1 true ES8502989A1 (es) 1985-02-01

Family

ID=27023342

Family Applications (2)

Application Number Title Priority Date Filing Date
ES525490A Expired ES8502989A1 (es) 1982-09-09 1983-09-08 Un metodo de preparar compuestos de diaminopirimidina
ES531004A Granted ES531004A0 (es) 1982-09-09 1984-03-27 Un metodo de preparar compuestos de diaminopirimidina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES531004A Granted ES531004A0 (es) 1982-09-09 1984-03-27 Un metodo de preparar compuestos de diaminopirimidina

Country Status (9)

Country Link
US (1) US4532240A (es)
EP (1) EP0103464B1 (es)
AU (2) AU560971B2 (es)
CA (1) CA1251447A (es)
DE (1) DE3378469D1 (es)
DK (1) DK158310C (es)
ES (2) ES8502989A1 (es)
GR (1) GR79058B (es)
IE (1) IE56148B1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE35053E (en) * 1985-09-12 1995-10-10 The Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
US5099019A (en) * 1985-09-12 1992-03-24 Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
LU86695A1 (fr) * 1986-12-01 1988-07-14 Oreal Nouveaux derives de piperazinyl-1 pyrimidine,leur preparation et leur application en therapeutique et cosmetique
HUT64323A (en) * 1992-06-09 1993-12-28 Richter Gedeon Vegyeszet Process for production new piperazinyl-bis(alkyl-amino)-pyrimidine derivatives
ATE166347T1 (de) * 1993-02-26 1998-06-15 Max Delbrueck Centrum Verfahren zur herstellung von c-nukleosiden und c-nukleosid-analoga, neue c-nukleoside und c- nukleosid-analoga, sowie ihre verwendung
DE4320570C2 (de) * 1993-02-26 2002-07-11 Max Delbrueck Centrum Verfahren zur Herstellung von C-Nukleosiden und C-Nukleosid-Analoga, neue C-Nukleoside und C-Nukleosid-Analoga sowie deren Verwendung
GB9801392D0 (en) * 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
US6451800B1 (en) 1998-01-30 2002-09-17 Meiji Seika Kaisha, Ltd. Phenylpiperazine derivatives as integrin αvβ3 antagonists
WO2000009131A1 (en) * 1998-08-13 2000-02-24 Warner-Lambert Company Diaminopyrimidines and combination therapies effective for treatment of p-glycoprotein positive cancers
US20040006042A1 (en) * 1998-08-13 2004-01-08 Berry David Allen Diaminopyrimidines and combination therapies effective for treatment of P-glycoprotein positive cancers
EP1389189A2 (en) 2001-05-22 2004-02-18 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
GB0412072D0 (en) 2004-05-28 2004-06-30 Syngenta Participations Ag Chemical compounds
JP6949055B2 (ja) * 2016-02-05 2021-10-13 ヴェラ ファーマシューティカルズ，エルエルシー 感染症を治療するための組成物および方法
WO2019032458A1 (en) * 2017-08-07 2019-02-14 Vyera Pharmaceuticals, LLC DHFR INHIBITORS, COMPOSITIONS AND RELATED METHODS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US416404A (en) 1889-12-03 Automatic lath-feeder for paper-carriers
NL72956C (es) * 1947-11-12
US2748125A (en) * 1954-04-26 1956-05-29 American Cyanamid Co 1-substituted-4-sulfamylpiperazine and method of preparing the same
AT340933B (de) * 1973-08-20 1978-01-10 Thomae Gmbh Dr K Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze
US4166852A (en) * 1974-08-09 1979-09-04 Produits Chimiques Ugine Kuhlmann Piperazino-pyrimidines and their use as spasmolytic agents
US4287338A (en) * 1980-03-10 1981-09-01 The Upjohn Company Sulfooxy-pyrimidinium, -pyridinium, and -triazinium hydroxide inner salts
US4351832A (en) * 1980-04-18 1982-09-28 American Home Products Corporation 2-(Piperazinyl)-4-pyrimidinamines

Also Published As

Publication number Publication date
EP0103464B1 (en) 1988-11-17
ES525490A0 (es) 1985-02-01
DK407383A (da) 1984-03-10
AU6878787A (en) 1987-05-14
DK158310B (da) 1990-04-30
US4532240A (en) 1985-07-30
EP0103464A3 (en) 1985-07-03
DE3378469D1 (en) 1988-12-22
IE56148B1 (en) 1991-05-08
GR79058B (es) 1984-10-02
ES8504775A1 (es) 1985-05-01
EP0103464A2 (en) 1984-03-21
CA1251447A (en) 1989-03-21
ES531004A0 (es) 1985-05-01
AU1869983A (en) 1984-03-15
DK158310C (da) 1990-10-15
IE831920L (en) 1984-03-09
AU568997B2 (en) 1988-01-14
AU560971B2 (en) 1987-04-30
DK407383D0 (da) 1983-09-08

Similar Documents

Publication Publication Date Title
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
BG103947A (en) Derivatives of 9-oxymerythromycin
BG103292A (en) 6-0-substituted ketolides possessing antibacterial effect
ES8506020A1 (es) Procedimiento para preparar derivados de 4-oxo-1, 4-dihidroquinoleina
FI952607A (fi) Farmakologisesti aktiiviset pyridiinijohdannaiset ja menetelmät niiden valmistamiseksi
ES8502989A1 (es) Un metodo de preparar compuestos de diaminopirimidina
CA2292359A1 (en) Novel azalides and methods of making same
BG104644A (en) Novel macrolides
BG101118A (en) Therapeutical compounds
BG105543A (en) Novel macrolide antibiotics
MX9803650A (es) Agentes antimicrobianos de benzoxazina.
AP2001002142A0 (en) 13-membered azalides and their use as antibiotic agents.
GT199900208A (es) Antibiòticos cetòlidos carbamato y carbazato.
HUT73433A (en) Process for preparing pharmaceutical compositions containing riluzole for treating aids-related neural disorders
MY131300A (en) Antibacterial agents
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
MX9708611A (es) Compuestos de dialquiltiacumicina.
ES482698A1 (es) Procedimiento para la obtencion de pseudotrisaceridos.
ES8403968A1 (es) Procedimiento para obtener compuestos antibioticos que contienen fosforo.
GEP20022840B (en) Form VI 5,6-Dichloro-2-(Isopropylamino)-1-(Beta-L-Ribofuranosyl-1H-Benzimidazole), Method for Their Production, Composition for Treating Virus Infections and Methods for Treatment
TR200003249T2 (tr) 2''-Deoksi higromisin türevleri
ES8601200A1 (es) Un procedimiento para preparar compuestos de 3-(2-haloetil)-4-oxopirazolo-(5, 1-d)-1, 2, 3, 5-tetrazin-8-carboxamida
AU576914B2 (en) 5-cyanopyridine-2-diazohydroxide, basic salts thereof
ES8403898A1 (es) Procedimiento para preparar derivados de ergolina.
MY103900A (en) 6-substituted 2'', 3''-dideoxynucleosides and pharmaceutical compositions